Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

Response Genetics Inc

+ Add to Watchlist

RGDX:US

0.4535 USD 0.0065 1.41%

As of 20:10:00 ET on 03/27/2015.

Snapshot for Response Genetics Inc (RGDX)

Open: 0.4600 Day's Range: 0.4401 - 0.4700 Volume: 7,555
Previous Close: 0.4600 52wk Range: 0.2533 - 1.5600 1-Yr Rtn: -59.87%

Stock Chart for RGDX

No chart data available.
  • RGDX:US 0.4535
  • 1D
  • 1M
  • 1Y
0.4600
Interactive RGDX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RGDX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.3500
Est. EPS (USD) (12/2014) -
Est. PEG Ratio -
Market Cap (M USD) 17.59
Shares Outstanding (M) 38.78
30 Day Average Volume 223,642
Price/Book (mrq) 8.7403
Price/Sale (ttm) 0.9885
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/31/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RGDX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for RGDX

Response Genetics, Inc. is a biopharmaceutical company that researches and develops pharmacogenomic diagnostic tests. The Company's products are targeted for potential use in the treatment of cancer.

Thomas A Bologna "Tom"Chairman/CEOKevin R HarrisVP/CFO
Adanech GetachewGeneral Counsel
More Company Profile & Key Executives for RGDX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil